This training program in dermatology will support pre- and post-doctoral candidate training in basic and clinical skin research. The training provided fulfills a unique niche in dermatology because the training faculties have expertise in bioengineering, nanotechnology and optics as well as traditional biology and clinical research. Training faculty have been selected for participation based on their success in mentoring. Skin biology-based studies are supported by diverse laboratory approaches involving protein chemistry, recombinant DNA technology, lipid biochemistry and gene regulation enabling a trainee to gain broad laboratory expertise. Trainees interested in Clinical research train in collaboration with the Clinical Translational Sciences Center and can obtain a Master's degree in Public Health. Finally, trainees interested in the interface between technology and medicine have the opportunity to study under the auspices of the Center For Future Health, where their research can focus on interdisciplinary applications for skin disease in collaboration with the faculty in Engineering, Optics, Biochemistry and Bioengineering. Both post-doctoral training and pre-doctoral training support is needed to entice non-biologically oriented trainees to skin-oriented projects. The pre-doctoral program is preferably five years in length with a focus on an academic career. Highly qualified candidates are selected from students enrolled in the predoctoral training programs of the departments of Optics, Engineering, Biochemistry and Bioengineering who express an interest in skin research. The postdoctoral program is a minimum of two, preferably three years in length. These trainees are identified from those applying directly to our research group or to our dermatology residency program. Training is provided to candidates through the use of multidisciplinary mentorship teams as well as defined curricula. The multidisciplinary approach this training program supports is intended to augment existing research areas within dermatology, but also to provide training to individuals from other disciplines not commonly participating in skin research to broaden our research capacity as a field.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Baker, Carl
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Rochester
Schools of Dentistry
United States
Zip Code
Kuo, I-Hsin; Yoshida, Takeshi; De Benedetto, Anna et al. (2013) The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol 131:266-78
Soong, Joanne; Scott, Glynis (2013) Plexin B1 inhibits MET through direct association and regulates Shp2 expression in melanocytes. J Cell Sci 126:688-95
Kuo, I-Hsin; Carpenter-Mendini, Amanda; Yoshida, Takeshi et al. (2013) Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 133:988-98
Pentland, Alice (2013) Building social and scientific networks to grow our global skin biology community. J Invest Dermatol 133:2497-9
Soong, Joanne; Chen, Yulin; Shustef, Elina M et al. (2012) Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth. J Invest Dermatol 132:1230-8
Palde, Prakash B; Ofori, Leslie O; Gareiss, Peter C et al. (2010) Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence. J Med Chem 53:6018-27
McNaughton, Brian R; Gareiss, Peter C; Jacobs, Stacey E et al. (2009) A potent activator of melanogenesis identified from small-molecule screening. ChemMedChem 4:1583-9
Gareiss, Peter C; Sobczak, Krzysztof; McNaughton, Brian R et al. (2008) Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). J Am Chem Soc 130:16254-61
Brouxhon, Sabine; Kyrkanides, Stephanos; O'Banion, M Kerry et al. (2007) Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism. Cancer Res 67:7654-64
McNaughton, Brian R; Gareiss, Peter C; Miller, Benjamin L (2007) Identification of a selective small-molecule ligand for HIV-1 frameshift-inducing stem-loop RNA from an 11,325 member resin bound dynamic combinatorial library. J Am Chem Soc 129:11306-7

Showing the most recent 10 out of 24 publications